Figure 1 (Eee07a52 1102 4d48 9782 26061db175ad 01)
Merilog Injection, Solution
Product Images NDC 0024-5927
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 38 technical images submitted to the FDA as part of the official labeling for Merilog (NDC 0024-5927). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Eee07a52 1102 4d48 9782 26061db175ad 02)
Figure A (Eee07a52 1102 4d48 9782 26061db175ad 03)
Figure B (Eee07a52 1102 4d48 9782 26061db175ad 04)
Figure C (Eee07a52 1102 4d48 9782 26061db175ad 05)
Figure D (Eee07a52 1102 4d48 9782 26061db175ad 06)
Figure E (Eee07a52 1102 4d48 9782 26061db175ad 07)
Figure F (Eee07a52 1102 4d48 9782 26061db175ad 08)
Figure G (Eee07a52 1102 4d48 9782 26061db175ad 09)
This seems to be a list of body parts for evaluating physical fitness or health. It mentions upper arms, stomach, buttocks, and thighs. These areas are commonly assessed for measurements, muscle tone, or body fat composition in various health and fitness evaluations.*
Figure H (Eee07a52 1102 4d48 9782 26061db175ad 10)
Figure I (Eee07a52 1102 4d48 9782 26061db175ad 11)
Figure A (Eee07a52 1102 4d48 9782 26061db175ad 12)
This text lists the parts of the body which may be the focus of a workout or exercise routine: upper arms, stomach, buttocks, and thighs. These areas are common targets for toning and strength-building exercises.*
Figure B (Eee07a52 1102 4d48 9782 26061db175ad 13)
This text provides a description of a cartridge holder for insulin injection. It includes features such as a dose window, dose pointer, dose selector, insulin plunger, and an injection button. Additionally, it notes that the plunger may not be visible until after injecting a few doses.*
Figure C (Eee07a52 1102 4d48 9782 26061db175ad 14)
Figure D (Eee07a52 1102 4d48 9782 26061db175ad 15)
Figure E (Eee07a52 1102 4d48 9782 26061db175ad 16)
This is a 3 mL Prefilled Pen - Merilog™ SoloStar, containing insulin aspart. It is for single patient use and has 50 units.*
Figure F (Eee07a52 1102 4d48 9782 26061db175ad 17)
Figure G (Eee07a52 1102 4d48 9782 26061db175ad 18)
Figure H (Eee07a52 1102 4d48 9782 26061db175ad 19)
Figure I (Eee07a52 1102 4d48 9782 26061db175ad 20)
Figure J (Eee07a52 1102 4d48 9782 26061db175ad 21)
Figure K (Eee07a52 1102 4d48 9782 26061db175ad 22)
Figure L (Eee07a52 1102 4d48 9782 26061db175ad 23)
Figure M (Eee07a52 1102 4d48 9782 26061db175ad 24)
Figure N (Eee07a52 1102 4d48 9782 26061db175ad 25)
Figure O (Eee07a52 1102 4d48 9782 26061db175ad 26)
Figure P (Eee07a52 1102 4d48 9782 26061db175ad 27)
Figure Q (Eee07a52 1102 4d48 9782 26061db175ad 28)
Figure R (Eee07a52 1102 4d48 9782 26061db175ad 29)
Figure S (Eee07a52 1102 4d48 9782 26061db175ad 30)
Figure T (Eee07a52 1102 4d48 9782 26061db175ad 31)
Figure U (Eee07a52 1102 4d48 9782 26061db175ad 32)
Figure V (Eee07a52 1102 4d48 9782 26061db175ad 33)
Figure W (Eee07a52 1102 4d48 9782 26061db175ad 34)
Principal Display Panel (3 mL Pen Carton)
This text reveals information about Meritog™ Solostar, an insulin product containing 100 units of insulin aspart per milliliter. The text provides details on the inactive ingredients, dosage, storage instructions, and usage precautions. It also includes helpful contact information and instructions for use. Remember to handle this medication cautiously and under proper medical supervision, following the guidelines provided for optimal storage and administration.*
Principal Display Panel (10 mL Vial Carton)
The text appears to be a description of a medication named Merilog™, specifically an insulin aspart injection at a concentration of 100 units/mL (U-100). It is intended for subcutaneous injection only and should be used with a U-100 syringe. The medication is stored refrigerated between 2°C to 8°C until first use, then may be stored refrigerated or at room temperature (up to 30°C) and discarded after 28 days. It is important not to freeze Merilog™ and to avoid exposing it to excessive heat or light. The medication should not be used past the expiration date and should be kept out of reach of children. The text also mentions the inactive ingredients in the medication and provides dosage information. Additional warnings and instructions are provided on the packaging insert.*
Principal Display Panel (10 mL Vial Label)
This is a description of Merilog, an insulin aspart injection in a 10 mL multiple-dose vial with a concentration of 100 units/mL (U-100). It is for subcutaneous injection only, and the dosage information should be consulted in the Prescribing Information. The product is manufactured by sanofi-aventis U.S. LLC and is available by prescription only under U.S. Lic. No. 1752.*
Principal Display Panel (3 mL Pen Label)
This is a 3 mL Prefilled Pen with Merilog™ SoloStar® which contains insulin aspart. It is for single patient use only, with a concentration of 100 units/mL (U-100). The product is for subcutaneous injection only and manufactured by sanofi-aventis U.S. LLC. The dosage information can be found in the Prescribing Information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
